The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various t...
Gespeichert in:
| Veröffentlicht in: | Arthritis research & therapy 2008-01, Vol.10 (3), p.208-208 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 208 |
|---|---|
| container_issue | 3 |
| container_start_page | 208 |
| container_title | Arthritis research & therapy |
| container_volume | 10 |
| creator | Smolen, Josef S Aletaha, Daniel Grisar, Johannes Redlich, Kurt Steiner, Günter Wagner, Oswald |
| description | Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various therapeutic modalities available today, especially biological agents, would provide means for optimization of care. In the present article, the current information on biological and clinical markers related to disease activity and joint damage as well as for predictive purposes is reviewed. It will be shown that the relationship of many biomarkers with disease characteristics is confounded by factors unrelated to the disease, and that only few biomarkers exist with some predictive value. Moreover, clinical markers appear of equal value as biomarkers for this purpose, although they likewise have limited capacity in these regards. The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified. |
| doi_str_mv | 10.1186/ar2418 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2483438</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1517413631</sourcerecordid><originalsourceid>FETCH-LOGICAL-b532t-69260290cd5e14faa418d939340f298bad2e3da0dc1af9f28e850bd616c690b83</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhi0EoqXAT0AWB24p_lrH5kBFK6BIlbiUs-W1Z7Muu3awd4n493WaqGmRerJH884z884g9JaSU0qV_GgzE1Q9Q8dULNVCcsme3_8bcYRelXJDCGOaiZfoiKqmWWpNj1F_3QOOAB53KeN1TquYyhScnVIuOESce5jHGgWPbZ76HKZQTvF5SENaVdmAbfTYDSHeBaPNvyGXT3jTQ4ZaAXhT-Wlz9hq96OxQ4M3-PUG_vn29vrhcXP38_uPiy9WibTibFlIzSZgmzjdARWdtdeU111yQjmnVWs-Ae0u8o7bTHVOgGtJ6SaWTmrSKn6DPO-56bkfwDuKU7WDWOdTZ_plkg3mciaE3q_TXMKG44FuA3gHakJ4APM64NJrd-mvth33znP7MUCYzhuJgGGyENBcjqw_dsK3w_X_CmzTnWBdjGF3Ws1GhDzSXUykZuvshKDHbqx_avnvo-SDbn5nfAkTSqrY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217478149</pqid></control><display><type>article</type><title>The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Smolen, Josef S ; Aletaha, Daniel ; Grisar, Johannes ; Redlich, Kurt ; Steiner, Günter ; Wagner, Oswald</creator><creatorcontrib>Smolen, Josef S ; Aletaha, Daniel ; Grisar, Johannes ; Redlich, Kurt ; Steiner, Günter ; Wagner, Oswald</creatorcontrib><description>Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various therapeutic modalities available today, especially biological agents, would provide means for optimization of care. In the present article, the current information on biological and clinical markers related to disease activity and joint damage as well as for predictive purposes is reviewed. It will be shown that the relationship of many biomarkers with disease characteristics is confounded by factors unrelated to the disease, and that only few biomarkers exist with some predictive value. Moreover, clinical markers appear of equal value as biomarkers for this purpose, although they likewise have limited capacity in these regards. The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified.</description><identifier>ISSN: 1478-6354</identifier><identifier>EISSN: 1478-6362</identifier><identifier>DOI: 10.1186/ar2418</identifier><identifier>PMID: 18557991</identifier><language>eng</language><publisher>England: National Library of Medicine - MEDLINE Abstracts</publisher><subject>Animals ; Arthritis, Rheumatoid - diagnosis ; Arthritis, Rheumatoid - metabolism ; Arthritis, Rheumatoid - pathology ; Biomarkers - metabolism ; Cytokines - metabolism ; Humans ; Prognosis ; Review</subject><ispartof>Arthritis research & therapy, 2008-01, Vol.10 (3), p.208-208</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts 2008</rights><rights>Copyright © 2008 BioMed Central Ltd 2008 BioMed Central Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b532t-69260290cd5e14faa418d939340f298bad2e3da0dc1af9f28e850bd616c690b83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483438/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483438/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18557991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smolen, Josef S</creatorcontrib><creatorcontrib>Aletaha, Daniel</creatorcontrib><creatorcontrib>Grisar, Johannes</creatorcontrib><creatorcontrib>Redlich, Kurt</creatorcontrib><creatorcontrib>Steiner, Günter</creatorcontrib><creatorcontrib>Wagner, Oswald</creatorcontrib><title>The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?</title><title>Arthritis research & therapy</title><addtitle>Arthritis Res Ther</addtitle><description>Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various therapeutic modalities available today, especially biological agents, would provide means for optimization of care. In the present article, the current information on biological and clinical markers related to disease activity and joint damage as well as for predictive purposes is reviewed. It will be shown that the relationship of many biomarkers with disease characteristics is confounded by factors unrelated to the disease, and that only few biomarkers exist with some predictive value. Moreover, clinical markers appear of equal value as biomarkers for this purpose, although they likewise have limited capacity in these regards. The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified.</description><subject>Animals</subject><subject>Arthritis, Rheumatoid - diagnosis</subject><subject>Arthritis, Rheumatoid - metabolism</subject><subject>Arthritis, Rheumatoid - pathology</subject><subject>Biomarkers - metabolism</subject><subject>Cytokines - metabolism</subject><subject>Humans</subject><subject>Prognosis</subject><subject>Review</subject><issn>1478-6354</issn><issn>1478-6362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1vEzEQhi0EoqXAT0AWB24p_lrH5kBFK6BIlbiUs-W1Z7Muu3awd4n493WaqGmRerJH884z884g9JaSU0qV_GgzE1Q9Q8dULNVCcsme3_8bcYRelXJDCGOaiZfoiKqmWWpNj1F_3QOOAB53KeN1TquYyhScnVIuOESce5jHGgWPbZ76HKZQTvF5SENaVdmAbfTYDSHeBaPNvyGXT3jTQ4ZaAXhT-Wlz9hq96OxQ4M3-PUG_vn29vrhcXP38_uPiy9WibTibFlIzSZgmzjdARWdtdeU111yQjmnVWs-Ae0u8o7bTHVOgGtJ6SaWTmrSKn6DPO-56bkfwDuKU7WDWOdTZ_plkg3mciaE3q_TXMKG44FuA3gHakJ4APM64NJrd-mvth33znP7MUCYzhuJgGGyENBcjqw_dsK3w_X_CmzTnWBdjGF3Ws1GhDzSXUykZuvshKDHbqx_avnvo-SDbn5nfAkTSqrY</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Smolen, Josef S</creator><creator>Aletaha, Daniel</creator><creator>Grisar, Johannes</creator><creator>Redlich, Kurt</creator><creator>Steiner, Günter</creator><creator>Wagner, Oswald</creator><general>National Library of Medicine - MEDLINE Abstracts</general><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080101</creationdate><title>The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?</title><author>Smolen, Josef S ; Aletaha, Daniel ; Grisar, Johannes ; Redlich, Kurt ; Steiner, Günter ; Wagner, Oswald</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b532t-69260290cd5e14faa418d939340f298bad2e3da0dc1af9f28e850bd616c690b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Arthritis, Rheumatoid - diagnosis</topic><topic>Arthritis, Rheumatoid - metabolism</topic><topic>Arthritis, Rheumatoid - pathology</topic><topic>Biomarkers - metabolism</topic><topic>Cytokines - metabolism</topic><topic>Humans</topic><topic>Prognosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smolen, Josef S</creatorcontrib><creatorcontrib>Aletaha, Daniel</creatorcontrib><creatorcontrib>Grisar, Johannes</creatorcontrib><creatorcontrib>Redlich, Kurt</creatorcontrib><creatorcontrib>Steiner, Günter</creatorcontrib><creatorcontrib>Wagner, Oswald</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arthritis research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smolen, Josef S</au><au>Aletaha, Daniel</au><au>Grisar, Johannes</au><au>Redlich, Kurt</au><au>Steiner, Günter</au><au>Wagner, Oswald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?</atitle><jtitle>Arthritis research & therapy</jtitle><addtitle>Arthritis Res Ther</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>10</volume><issue>3</issue><spage>208</spage><epage>208</epage><pages>208-208</pages><issn>1478-6354</issn><eissn>1478-6362</eissn><abstract>Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations, serologic abnormalities, joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various therapeutic modalities available today, especially biological agents, would provide means for optimization of care. In the present article, the current information on biological and clinical markers related to disease activity and joint damage as well as for predictive purposes is reviewed. It will be shown that the relationship of many biomarkers with disease characteristics is confounded by factors unrelated to the disease, and that only few biomarkers exist with some predictive value. Moreover, clinical markers appear of equal value as biomarkers for this purpose, although they likewise have limited capacity in these regards. The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified.</abstract><cop>England</cop><pub>National Library of Medicine - MEDLINE Abstracts</pub><pmid>18557991</pmid><doi>10.1186/ar2418</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1478-6354 |
| ispartof | Arthritis research & therapy, 2008-01, Vol.10 (3), p.208-208 |
| issn | 1478-6354 1478-6362 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2483438 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; PubMed Central; Springer Nature OA/Free Journals |
| subjects | Animals Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - metabolism Arthritis, Rheumatoid - pathology Biomarkers - metabolism Cytokines - metabolism Humans Prognosis Review |
| title | The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A00%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20need%20for%20prognosticators%20in%20rheumatoid%20arthritis.%20Biological%20and%20clinical%20markers:%20where%20are%20we%20now?&rft.jtitle=Arthritis%20research%20&%20therapy&rft.au=Smolen,%20Josef%20S&rft.date=2008-01-01&rft.volume=10&rft.issue=3&rft.spage=208&rft.epage=208&rft.pages=208-208&rft.issn=1478-6354&rft.eissn=1478-6362&rft_id=info:doi/10.1186/ar2418&rft_dat=%3Cproquest_pubme%3E1517413631%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=217478149&rft_id=info:pmid/18557991&rfr_iscdi=true |